SCM

Sarissa Capital Management Portfolio holdings

AUM $154M
This Quarter Return
+2.77%
1 Year Return
-6.05%
3 Year Return
-7.91%
5 Year Return
+32.47%
10 Year Return
+262.41%
AUM
$1.04B
AUM Growth
+$1.04B
Cap. Flow
+$68.5M
Cap. Flow %
6.57%
Top 10 Hldgs %
99.69%
Holding
14
New
2
Increased
2
Reduced
3
Closed
–

Top Buys

1
GILD icon
Gilead Sciences
GILD
$174M
2
VOR icon
Vor Biopharma
VOR
$30.5M
3
IRWD icon
Ironwood Pharmaceuticals
IRWD
$26.3M
4
MRSN icon
Mersana Therapeutics
MRSN
$17.5M

Top Sells

1
JAZZ icon
Jazz Pharmaceuticals
JAZZ
$152M
2
ALXN
Alexion Pharmaceuticals Inc
ALXN
$22.5M
3
BCRX icon
BioCryst Pharmaceuticals
BCRX
$5.46M

Sector Composition

1 Healthcare 99.52%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
IRWD icon
1
Ironwood Pharmaceuticals
IRWD
$214M
$183M 17.56% 16,390,000 +2,350,000 +17% +$26.3M
BIIB icon
2
Biogen
BIIB
$19.4B
$180M 17.24% 643,000 – –
GILD icon
3
Gilead Sciences
GILD
$140B
$174M 16.71% +2,697,400 New +$174M
ALKS icon
4
Alkermes
ALKS
$4.78B
$149M 14.23% 7,950,000 – –
ALXN
5
DELISTED
Alexion Pharmaceuticals Inc
ALXN
$99.5M 9.53% 650,440 -147,300 -18% -$22.5M
BCRX icon
6
BioCryst Pharmaceuticals
BCRX
$1.74B
$77.7M 7.45% 7,637,700 -537,300 -7% -$5.46M
INVA icon
7
Innoviva
INVA
$1.29B
$76.6M 7.35% 6,414,000 – –
MRSN icon
8
Mersana Therapeutics
MRSN
$36.5M
$64.8M 6.21% 4,005,600 +1,078,600 +37% +$17.5M
VOR icon
9
Vor Biopharma
VOR
$250M
$30.5M 2.92% +707,010 New +$30.5M
SRSAW
10
DELISTED
Sarissa Capital Acquisition Corp. Warrants
SRSAW
$5M 0.48% 3,333,333 – –
RGLS
11
DELISTED
Regulus Therapeutics
RGLS
$2.89M 0.28% 1,851,851 – –
MRTX
12
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$171K 0.02% 1,000 – –
JAZZ icon
13
Jazz Pharmaceuticals
JAZZ
$7.75B
$164K 0.02% 1,000 -927,100 -100% -$152M
ICPT
14
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$21K ﹤0.01% 950 – –